BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $125,658 | -15.4% | 20,978 | 0.0% | 0.00% | -33.3% |
| Q3 2023 | $148,524 | +11.2% | 20,978 | +10.6% | 0.01% | +20.0% |
| Q2 2023 | $133,576 | -15.6% | 18,974 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $158,243 | +71503.2% | 18,974 | -1.4% | 0.01% | -33.3% |
| Q4 2022 | $221 | -99.9% | 19,237 | -1.4% | 0.01% | -18.2% |
| Q3 2022 | $246,000 | +20.0% | 19,515 | +0.6% | 0.01% | +22.2% |
| Q2 2022 | $205,000 | -30.7% | 19,408 | +6.6% | 0.01% | -10.0% |
| Q1 2022 | $296,000 | +17.5% | 18,208 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $252,000 | – | 18,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |